Veterinary Medicines

CANIGEN DHPPI/L

Authorised
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
Download as PDF

Product identification

Medicine name:
CANIGEN DHPPI/L
Active substance:
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle, Live
    1000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan, Live
    10000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain Manhattan, Live
    100000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine parvovirus, strain Cornell 780916, Live
    100000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    1.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    unit(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
    1.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4541237 6/1993
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."